<DOC>
	<DOCNO>NCT01036438</DOCNO>
	<brief_summary>Compare efficacy use absorbent foam silver dressing ( Mepilex Ag ) versus equivalent dress without silver subject suffer venous leg ulcer mixed ulcer ABPI ≥ 0.8 inflammatory sign . Efficacy define absolute wound size reduction .</brief_summary>
	<brief_title>Evaluating Efficacy Absorbent Foam Dressing Containing Silver ( Mepilex Ag ) Versus Same Dressing Without Silver Used Subjects With Venous Leg Ulcers Mixed Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Varicose Ulcer</mesh_term>
	<criteria>Subjects colonised/ local infection venous leg ulcer mixed leg ulcer ABPI ≥ 0,8 &lt; 1.3 A history appropriate compression therapy least 2 week prior randomisation Subjects colonised/local infection present three five follow specify sign : pain dressing change exude wound erythema periwound skin oedema odour An ulcer size least 4 cm2 maximum size witch could cover one investigational product 15x15 cm . Ulcer duration 6 week 1 year In case multiple ulcer : target ulcer must least 3 cm distant ulcer . Both gender age ≥ 18 year Signed informed consent &gt; 10 % necrotic ( black ) fibrinous ( yellow ) tissue cover wound bed Infected wound need systemic antibiotic treatment Use antimicrobial dressing topical agent antiseptic , local antibiotic steroid within 7 day inclusion wound intend include Previous treatment silver product 2 week prior inclusion Previous treatment MepilexAg® target ulcer Use systemic antibiotic reason previous 7 day Venous surgery 2 week prior inclusion plan surgery within 8 week inclusion Diagnosed underlying disease ( ) ( e.g . HIV/AIDS , cancer/malignancy severe anaemia ) judge investigator potential interference wound evaluation Subjects poorly control diabetes mellitus i.e . HbA1c &gt; 8 % Subjects treat systemic immunosuppressive glucocorticosteroids , except subject take occasional dos dose less 10mg prednisolon/day equivalent . Subjects inhale glucocorticosteroids asthma exclude . Known allergy/hypersensitivity component investigation product . Subjects physical and/or mental condition expect comply investigation due poor medical condition Participation clinical investigation ( ) within 1 month prior start investigation . Previously randomise investigation . Life expectance subject le 3 month Pregnant breastfeed woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>